Bio-Techne TECH Balance Sheet Statement
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| $209.82M+49.2% | $172.88M-2.6% | $144.96M-22.7% | $162.19M+6.8% | $140.67M+0.5% | ||
| $214.56M-9.5% | $184.61M-15.3% | $183.9M-17.8% | $206.88M-14.3% | $237.14M+4.1% | ||
| $799.26M+7.4% | $789.16M+7.7% | $772.09M+6.5% | $753.94M+3.8% | $744.23M+3.6% | ||
| $688.05M+9.7% | $637.43M+0.4% | $609.51M-6.0% | $608.3M-1.5% | $627.24M+2.7% | ||
| $232.99M-7.5% | $234.38M-6.2% | $240.33M-5.4% | $245.72M-2.2% | $251.98M+3.4% | ||
| $977.8M+0.9% | $980.56M+1.7% | $978.91M-0.4% | $980.94M+0.9% | $968.61M-0.2% | ||
| $319.07M-28.1% | $334.99M-27.3% | $350.11M-28.0% | $365.6M-27.9% | $443.7M-15.7% | ||
| $2.55B-3.5% | $2.52B-5.5% | $2.53B-7.7% | $2.56B-5.4% | $2.64B-2.8% | ||
| $23.49M-25.8% | $26.27M-20.7% | $30.16M-4.4% | $25.31M-33.3% | $31.64M+9.5% | ||
| $38.43M+19.1% | $31.03M+12.0% | $30.45M+14.4% | $32.57M+16.6% | $32.27M+7.2% | ||
| $153.28M-9.4% | $140.43M-12.9% | $144.55M+1.7% | $175.85M+10.3% | $169.2M+12.9% | ||
| $200M-39.4% | $260M-13.3% | $300M0.0% | $346M+8.5% | $330M-15.2% | ||
| $1.57M-0.2% | $1.56M-1.3% | $1.56M-2.0% | $1.55M-2.0% | $1.57M-0.5% | ||
| $1.15B-4.3% | $1.11B-14.0% | $1.08B-19.3% | $1.07B-19.6% | $1.2B-7.8% | ||
| —— | —— | —— | $1.92B-7.3% | $2.02B+0.2% | ||
| $2.55B-3.5% | $2.52B-5.5% | $2.53B-7.7% | $2.56B-5.4% | $2.64B-2.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Bio-Techne's total assets?
- Bio-Techne (TECH) holds $2.6B in total assets, down 3.5% year over year.
- How much debt does Bio-Techne have?
- Bio-Techne carries $290.3M in total debt against $2.1B of shareholders' equity, a debt-to-equity ratio of 0.14.
- How much cash does Bio-Techne have?
- Bio-Techne holds $209.8M in cash and equivalents.
- Can Bio-Techne cover its short-term obligations?
- Its current ratio is 4.49 — current assets exceed current liabilities.
- Where does Bio-Techne's balance sheet data come from?
- Every line is extracted from Bio-Techne's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
